{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:19:00Z","timestamp":1793060340363,"version":"4.5.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T00:00:00Z","timestamp":1522368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s12035-018-1032-x","type":"journal-article","created":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T06:39:53Z","timestamp":1522391993000},"page":"8826-8841","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":166,"title":["MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"55","author":[{"given":"Paul M.","family":"McKeever","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foad","family":"Taghdiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Weichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namita","family":"Multani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Boxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Karydas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmela","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,30]]},"reference":[{"key":"1032_CR1","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A et al (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature 349:704\u2013706. https:\/\/doi.org\/10.1038\/349704a0","journal-title":"Nature"},{"key":"1032_CR2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C et al (1995) Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene. Nature 376:775\u2013778. https:\/\/doi.org\/10.1038\/376775a0","journal-title":"Nature"},{"key":"1032_CR3","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, Rogaev EI, Liang Y et al (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature 375:754\u2013760. https:\/\/doi.org\/10.1038\/375754a0","journal-title":"Nature"},{"key":"1032_CR4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1086\/302553","volume":"65","author":"D Campion","year":"1999","unstructured":"Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M, Thomas-Anterion C, Michon A et al (1999) Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 65:664\u2013670","journal-title":"Am J Hum Genet"},{"key":"1032_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1212\/01.WNL.0000042088.22694.E3","volume":"60","author":"JC Janssen","year":"2003","unstructured":"Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, Harvey RJ, Houlden H, Rossor MN et al (2003) Early onset familial Alzheimer\u2019s disease: mutation frequency in 31 families. Neurology 60:235\u2013239","journal-title":"Neurology"},{"key":"1032_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3233\/JAD-132273","volume":"41","author":"H Eriksson","year":"2014","unstructured":"Eriksson H, Fereshtehnejad S-M, Falahati F, Farahmand B, Religa D, Eriksdotter M (2014) Differences in routine clinical practice between early and late onset Alzheimer\u2019s disease: data from the Swedish Dementia Registry (SveDem). J Alzheimers Dis 41:411\u2013419","journal-title":"J Alzheimers Dis"},{"key":"1032_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/jnnp.2003.029876","volume":"76","author":"GB Frisoni","year":"2005","unstructured":"Frisoni GB (2005) Structural correlates of early and late onset Alzheimer\u2019s disease: voxel based morphometric study. J Neurol Neurosurg Psychiatry 76:112\u2013114. https:\/\/doi.org\/10.1136\/jnnp.2003.029876","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1032_CR8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1447-0594.2012.00934.x","volume":"13","author":"M Sakai","year":"2013","unstructured":"Sakai M, Hanyu H, Kume K, Sato T, Hirao K, Kanetaka H, Abe S, Kanaya K et al (2013) Rate of progression of Alzheimer\u2019s disease in younger versus older patients: a longitudinal single photon emission computed tomography study: effect of age on AD progression. Geriatr Gerontol Int 13:555\u2013562. https:\/\/doi.org\/10.1111\/j.1447-0594.2012.00934.x","journal-title":"Geriatr Gerontol Int"},{"key":"1032_CR9","first-page":"212","volume":"7","author":"D Nochlin","year":"1993","unstructured":"Nochlin D, van Belle G, Bird TD, Sumi SM (1993) Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer\u2019s disease. Alzheimer Dis Assoc Disord 7:212\u2013222","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1032_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1212\/WNL.46.1.136","volume":"46","author":"E Koss","year":"1996","unstructured":"Koss E, Edland S, Fillenbaum G, Mohs R, Clark C, Galasko D, Morris JC (1996) Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer\u2019s disease: a CERAD analysis, part XII. Neurology 46:136\u2013141","journal-title":"Neurology"},{"key":"1032_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1001\/archneur.1983.04050030037006","volume":"40","author":"B Seltzer","year":"1983","unstructured":"Seltzer B, Sherwin I (1983) A comparison of clinical features in early-and late-onset primary degenerative dementia: one entity or two? Arch Neurol 40:143\u2013146","journal-title":"Arch Neurol"},{"key":"1032_CR12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1212\/WNL.44.7.1215","volume":"44","author":"D Jacobs","year":"1994","unstructured":"Jacobs D, Sano M, Marder K, Bell K, Bylsma F, Lafleche G, Albert M, Brandt J et al (1994) Age at onset of Alzheimer\u2019s disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology 44:1215\u20131220","journal-title":"Neurology"},{"key":"1032_CR13","first-page":"69","volume":"134","author":"R Katzman","year":"1988","unstructured":"Katzman R (1988) Alzheimer\u2019s disease as an age-dependent disorder. CIBA Found Symp 134:69\u201385","journal-title":"CIBA Found Symp"},{"key":"1032_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1532-5415.1989.tb05681.x","volume":"37","author":"E Ortof","year":"1989","unstructured":"Ortof E, Crystal HA (1989) Rate of progression of Alzheimer\u2019s disease. J Am Geriatr Soc 37:511\u2013514","journal-title":"J Am Geriatr Soc"},{"key":"1032_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/jnnp.65.2.184","volume":"65","author":"JV Bowler","year":"1998","unstructured":"Bowler JV, Munoz DG, Merskey H, Hachinski V (1998) Factors affecting the age of onset and rate of progression of Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 65:184\u2013190","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1032_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:263\u2013269. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005","journal-title":"Alzheimers Dement"},{"key":"1032_CR17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr et al (2011) Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:280\u2013292. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003","journal-title":"Alzheimers Dement"},{"key":"1032_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jalz.2014.02.004","volume":"11","author":"K Blennow","year":"2015","unstructured":"Blennow K, Dubois B, Fagan AM, Lewczuk P, de Leon MJ, Hampel H (2015) Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer\u2019s disease. Alzheimers Dement 11:58\u201369. https:\/\/doi.org\/10.1016\/j.jalz.2014.02.004","journal-title":"Alzheimers Dement"},{"key":"1032_CR19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U, \u00d6hrfelt A, Portelius E, Bjerke M, H\u00f6ltt\u00e4 M, Ros\u00e9n C et al (2016) CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol 15:673\u2013684","journal-title":"Lancet Neurol"},{"key":"1032_CR20","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1001\/archneurol.2009.55","volume":"66","author":"BJ Snider","year":"2009","unstructured":"Snider BJ, Fagan AM, Roe C, Shah AR, Grant EA, Xiong C, Morris JC, Holtzman DM (2009) Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type. Arch Neurol 66:638\u2013645","journal-title":"Arch Neurol"},{"key":"1032_CR21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/WAD.0b013e3181d712d9","volume":"24","author":"L Koric","year":"2010","unstructured":"Koric L, Felician O, Guedj E, Hubert AM, Mancini J, Boucraut J, Ceccaldi M (2010) Could clinical profile influence CSF biomarkers in early-onset Alzheimer disease? Alzheimer Dis Assoc Disord 24:278\u2013283. https:\/\/doi.org\/10.1097\/WAD.0b013e3181d712d9","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1032_CR22","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.neurobiolaging.2008.02.007","volume":"30","author":"FH Bouwman","year":"2009","unstructured":"Bouwman FH, Schoonenboom NSM, Verwey NA, van Elk EJ, Kok A, Blankenstein MA, Scheltens P, van der Flier WM (2009) CSF biomarker levels in early and late onset Alzheimer\u2019s disease. Neurobiol Aging 30:1895\u20131901. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.02.007","journal-title":"Neurobiol Aging"},{"key":"1032_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cell.2007.12.024","volume":"132","author":"A Eulalio","year":"2008","unstructured":"Eulalio A, Huntzinger E, Izaurralde E (2008) Getting to the root of miRNA-mediated gene silencing. Cell 132:9\u201314. https:\/\/doi.org\/10.1016\/j.cell.2007.12.024","journal-title":"Cell"},{"key":"1032_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrg3965","volume":"16","author":"S Jonas","year":"2015","unstructured":"Jonas S, Izaurralde E (2015) Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet 16:421\u2013433. https:\/\/doi.org\/10.1038\/nrg3965","journal-title":"Nat Rev Genet"},{"key":"1032_CR25","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1073\/pnas.1019055108","volume":"108","author":"JD Arroyo","year":"2011","unstructured":"Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF et al (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci 108:5003\u20135008. https:\/\/doi.org\/10.1073\/pnas.1019055108","journal-title":"Proc Natl Acad Sci"},{"key":"1032_CR26","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1093\/nar\/gkr254","volume":"39","author":"A Turchinovich","year":"2011","unstructured":"Turchinovich A, Weiz L, Langheinz A, Burwinkel B (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res 39:7223\u20137233. https:\/\/doi.org\/10.1093\/nar\/gkr254","journal-title":"Nucleic Acids Res"},{"key":"1032_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ncb2210","volume":"13","author":"KC Vickers","year":"2011","unstructured":"Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13:423\u2013433. https:\/\/doi.org\/10.1038\/ncb2210","journal-title":"Nat Cell Biol"},{"key":"1032_CR28","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstr\u00f6m K, Bossios A, Sj\u00f6strand M, Lee JJ, L\u00f6tvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654\u2013659. https:\/\/doi.org\/10.1038\/ncb1596","journal-title":"Nat Cell Biol"},{"key":"1032_CR29","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v3.23743","volume":"3","author":"L Cheng","year":"2014","unstructured":"Cheng L, Sharples RA, Scicluna BJ, Hill AF (2014) Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles 3:23743. https:\/\/doi.org\/10.3402\/jev.v3.23743","journal-title":"J Extracell Vesicles"},{"key":"1032_CR30","doi-asserted-by":"publisher","first-page":"14888","DOI":"10.1073\/pnas.1408301111","volume":"111","author":"JR Chevillet","year":"2014","unstructured":"Chevillet JR, Kang Q, Ruf IK, Briggs HA, Vojtech LN, Hughes SM, Cheng HH, Arroyo JD et al (2014) Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci 111:14888\u201314893. https:\/\/doi.org\/10.1073\/pnas.1408301111","journal-title":"Proc Natl Acad Sci"},{"key":"1032_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2016.10.042","volume":"636","author":"Y Yagi","year":"2017","unstructured":"Yagi Y, Ohkubo T, Kawaji H, Machida A, Miyata H, Goda S, Roy S, Hayashizaki Y et al (2017) Next-generation sequencing-based small RNA profiling of cerebrospinal fluid exosomes. Neurosci Lett 636:48\u201357. https:\/\/doi.org\/10.1016\/j.neulet.2016.10.042","journal-title":"Neurosci Lett"},{"key":"1032_CR32","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/cr.2017.62","volume":"27","author":"B Xu","year":"2017","unstructured":"Xu B, Zhang Y, Du X-F et al (2017) Neurons secrete miR-132-containing exosomes to regulate brain vascular integrity. Cell Res 27:882\u2013897. https:\/\/doi.org\/10.1038\/cr.2017.62","journal-title":"Cell Res"},{"key":"1032_CR33","doi-asserted-by":"publisher","DOI":"10.4137\/JEN.S39916","volume":"10s1","author":"C Lafourcade","year":"2016","unstructured":"Lafourcade C, Ram\u00edrez JP, Luarte A, Fern\u00e1ndez A, Wyneken U (2016) MIRNAS in astrocyte-derived exosomes as possible mediators of neuronal plasticity: supplementary issue: brain plasticity and repair. J Exp Neurosci 10s1:JEN.S39916. https:\/\/doi.org\/10.4137\/JEN.S39916","journal-title":"J Exp Neurosci"},{"key":"1032_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3727\/096368916X693031","volume":"26","author":"H Xin","year":"2017","unstructured":"Xin H, Wang F, Li Y, Lu QE, Cheung WL, Zhang Y, Zhang ZG, Chopp M (2017) Secondary release of exosomes from astrocytes contributes to the increase in neural plasticity and improvement of functional recovery after stroke in rats treated with exosomes harvested from microRNA 133b-overexpressing multipotent mesenchymal stromal cells. Cell Transplant 26:243\u2013257. https:\/\/doi.org\/10.3727\/096368916X693031","journal-title":"Cell Transplant"},{"key":"1032_CR35","doi-asserted-by":"publisher","first-page":"11172","DOI":"10.1073\/pnas.0603838103","volume":"103","author":"L Rajendran","year":"2006","unstructured":"Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, Simons K (2006) Alzheimer\u2019s disease \u03b2-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci 103:11172\u201311177","journal-title":"Proc Natl Acad Sci"},{"key":"1032_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.febslet.2014.11.027","volume":"589","author":"K Yuyama","year":"2015","unstructured":"Yuyama K, Sun H, Usuki S, Sakai S, Hanamatsu H, Mioka T, Kimura N, Okada M et al (2015) A potential function for neuronal exosomes: Sequestering intracerebral amyloid-\u03b2 peptide. FEBS Lett 589:84\u201388. https:\/\/doi.org\/10.1016\/j.febslet.2014.11.027","journal-title":"FEBS Lett"},{"key":"1032_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jalz.2016.08.012","volume":"13","author":"ED Hamlett","year":"2017","unstructured":"Hamlett ED, Goetzl EJ, Ledreux A, Vasilevko V, Boger HA, LaRosa A, Clark D, Carroll SL et al (2017) Neuronal exosomes reveal Alzheimer\u2019s disease biomarkers in Down syndrome. Alzheimers Dement 13:541\u2013549. https:\/\/doi.org\/10.1016\/j.jalz.2016.08.012","journal-title":"Alzheimers Dement"},{"key":"1032_CR38","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.bbadis.2016.06.001","volume":"1862","author":"S Kumar","year":"2016","unstructured":"Kumar S, Reddy PH (2016) Are circulating microRNAs peripheral biomarkers for Alzheimer\u2019s disease? Biochim Biophys Acta (BBA) - Mol Basis Dis 1862:1617\u20131627. https:\/\/doi.org\/10.1016\/j.bbadis.2016.06.001","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"1032_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3233\/JAD-130932","volume":"39","author":"T Kiko","year":"2014","unstructured":"Kiko T, Nakagawa K, Tsuduki T, Furukawa K, Arai H, Miyazawa T (2014) MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer\u2019s disease. J Alzheimers Dis 39:253\u2013259","journal-title":"J Alzheimers Dis"},{"key":"1032_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3233\/JAD-2008-14103","volume":"14","author":"JP Cogswell","year":"2008","unstructured":"Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, Kelnar K, Kemppainen J et al (2008) Identification of miRNA changes in Alzheimer\u2019s disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 14:27\u201341","journal-title":"J Alzheimers Dis"},{"key":"1032_CR41","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3233\/JAD-161179","volume":"57","author":"J Riancho","year":"2017","unstructured":"Riancho J, V\u00e1zquez-Higuera JL, Pozueta A, Lage C, Kazimierczak M, Bravo M, Calero M, Gonalez\u00e1lez A et al (2017) MicroRNA profile in patients with Alzheimer\u2019s disease: analysis of miR-9-5p and miR-598 in raw and exosome enriched cerebrospinal fluid samples. J Alzheimers Dis 57:483\u2013491. https:\/\/doi.org\/10.3233\/JAD-161179","journal-title":"J Alzheimers Dis"},{"key":"1032_CR42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neurobiolaging.2013.07.005","volume":"35","author":"M M\u00fcller","year":"2014","unstructured":"M\u00fcller M, Kuiperij HB, Claassen JA, K\u00fcsters B, Verbeek MM (2014) MicroRNAs in Alzheimer\u2019s disease: differential expression in hippocampus and cell-free cerebrospinal fluid. Neurobiol Aging 35:152\u2013158. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.07.005","journal-title":"Neurobiol Aging"},{"key":"1032_CR43","first-page":"365","volume":"3","author":"PN Alexandrov","year":"2012","unstructured":"Alexandrov PN, Dua P, Hill JM, Bhattacharjee S, Zhao Y, Lukiw WJ (2012) microRNA (miRNA) speciation in Alzheimer\u2019s disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int J Biochem Mol Biol 3:365\u2013373","journal-title":"Int J Biochem Mol Biol"},{"key":"1032_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094839","volume":"9","author":"K Burgos","year":"2014","unstructured":"Burgos K, Malenica I, Metpally R, Courtright A, Rakela B, Beach T, Shill H, Adler C et al (2014) Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer\u2019s and Parkinson\u2019s diseases correlate with disease status and features of pathology. PLoS One 9:e94839. https:\/\/doi.org\/10.1371\/journal.pone.0094839","journal-title":"PLoS One"},{"key":"1032_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126423","volume":"10","author":"J Denk","year":"2015","unstructured":"Denk J, Boelmans K, Siegismund C, Lassner D, Arlt S, Jahn H (2015) MicroRNA profiling of CSF reveals potential biomarkers to detect Alzheimer\u2019s disease. PLoS One 10:e0126423. https:\/\/doi.org\/10.1371\/journal.pone.0126423","journal-title":"PLoS One"},{"key":"1032_CR46","doi-asserted-by":"publisher","first-page":"37043","DOI":"10.18632\/oncotarget.6158","volume":"6","author":"Y Gui","year":"2015","unstructured":"Gui Y, Liu H, Zhang L, Lv W, Hu X (2015) Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget 6:37043\u201337053","journal-title":"Oncotarget"},{"key":"1032_CR47","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3233\/JAD-140756","volume":"42","author":"D Galimberti","year":"2014","unstructured":"Galimberti D, Villa C, Fenoglio C, Serpente M, Ghezzi L, Cioffi SM, Arighi A, Fumagalli G et al (2014) Circulating miRNAs as potential biomarkers in Alzheimer\u2019s disease. J Alzheimers Dis 42:1261\u20131267","journal-title":"J Alzheimers Dis"},{"key":"1032_CR48","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-016-0053-5","volume":"5","author":"SS S\u00f8rensen","year":"2016","unstructured":"S\u00f8rensen SS, Nygaard A-B, Christensen T (2016) miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer\u2019s disease and other types of dementia\u2014an exploratory study. Transl Neurodegener 5:6. https:\/\/doi.org\/10.1186\/s40035-016-0053-5","journal-title":"Transl Neurodegener"},{"key":"1032_CR49","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.neurobiolaging.2012.12.026","volume":"34","author":"A Antonell","year":"2013","unstructured":"Antonell A, Llad\u00f3 A, Altirriba J, Botta-Orfila T, Balasa M, Fern\u00e1ndez M, Ferrer I, S\u00e1nchez-Valle R et al (2013) A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer\u2019s disease. Neurobiol Aging 34:1772\u20131778. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.12.026","journal-title":"Neurobiol Aging"},{"key":"1032_CR50","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/jmri.21049","volume":"27","author":"CR Jack","year":"2008","unstructured":"Jack CR, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ et al (2008) The Alzheimer\u2019s disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging 27:685\u2013691. https:\/\/doi.org\/10.1002\/jmri.21049","journal-title":"J Magn Reson Imaging"},{"key":"1032_CR51","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","volume":"52","author":"F Hulstaert","year":"1999","unstructured":"Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneider M, Deyn PPD, Bancher C, Cras P et al (1999) Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF. Neurology 52:1555\u20131562","journal-title":"Neurology"},{"key":"1032_CR52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1602\/neurorx.1.2.213","volume":"1","author":"K Blennow","year":"2004","unstructured":"Blennow K (2004) Cerebrospinal fluid protein biomarkers for Alzheimer\u2019s disease. NeuroRx 1:213\u2013225","journal-title":"NeuroRx"},{"key":"1032_CR53","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695\u2013699","journal-title":"J Am Geriatr Soc"},{"key":"1032_CR54","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1017\/S0317167100003930","volume":"32","author":"S Darvesh","year":"2005","unstructured":"Darvesh S, Leach L, Black SE, Kaplan E, Freedman M (2005) The Behavioural Neurology Assessment. Can J Neurol Sci J Can Sci Neurol 32:167\u2013177. https:\/\/doi.org\/10.1017\/S0317167100003930","journal-title":"Can J Neurol Sci J Can Sci Neurol"},{"key":"1032_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele J, De Preter K, Pattyn F et al (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:1","journal-title":"Genome Biol"},{"key":"1032_CR56","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","volume":"64","author":"CL Andersen","year":"2004","unstructured":"Andersen CL, Jensen JL, \u00d8rntoft TF (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64:5245\u20135250","journal-title":"Cancer Res"},{"key":"1032_CR57","doi-asserted-by":"publisher","first-page":"8191","DOI":"10.1007\/s12035-016-0316-2","volume":"54","author":"W-X Wang","year":"2017","unstructured":"Wang W-X, Fardo DW, Jicha GA, Nelson PT (2017) A customized quantitative PCR microRNA panel provides a technically robust context for studying neurodegenerative disease biomarkers and indicates a high correlation between cerebrospinal fluid and choroid plexus microRNA expression. Mol Neurobiol 54:8191\u20138202. https:\/\/doi.org\/10.1007\/s12035-016-0316-2","journal-title":"Mol Neurobiol"},{"key":"1032_CR58","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611\u2013622. https:\/\/doi.org\/10.1373\/clinchem.2008.112797","journal-title":"Clin Chem"},{"key":"1032_CR59","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25:402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"1032_CR60","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837\u2013845","journal-title":"Biometrics"},{"key":"1032_CR61","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/cc3000","volume":"8","author":"V Bewick","year":"2004","unstructured":"Bewick V, Cheek L, Ball J (2004) Statistics review 13: receiver operating characteristic curves. Crit Care 8:508\u2013512","journal-title":"Crit Care"},{"key":"1032_CR62","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373\u20131379","journal-title":"J Clin Epidemiol"},{"key":"1032_CR63","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, M\u00fcller M (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12:77","journal-title":"BMC Bioinformatics"},{"key":"1032_CR64","doi-asserted-by":"crossref","unstructured":"Maindonald JH, Braun J (2010) Data analysis and graphics using R: an example-based approach, 3rd ed. Cambridge University Press, Cambridge; New York","DOI":"10.1017\/CBO9781139194648"},{"key":"1032_CR65","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F","volume":"19","author":"J Carpenter","year":"2000","unstructured":"Carpenter J, Bithell J (2000) Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med 19:1141\u20131164","journal-title":"Stat Med"},{"key":"1032_CR66","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam J-W, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. elife 4:e05005","journal-title":"elife"},{"key":"1032_CR67","doi-asserted-by":"crossref","unstructured":"Thiem A, Du\u015fa A (2013) QCA: a package for qualitative comparative analysis. R J 5","DOI":"10.1007\/978-1-4614-4584-5"},{"key":"1032_CR68","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1002\/pmic.201500260","volume":"15","author":"A Benito-Martin","year":"2015","unstructured":"Benito-Martin A, Peinado H (2015) FunRich proteomics software analysis, let the fun begin! Proteomics 15:2555\u20132556. https:\/\/doi.org\/10.1002\/pmic.201500260","journal-title":"Proteomics"},{"key":"1032_CR69","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80","journal-title":"Genome Biol"},{"key":"1032_CR70","doi-asserted-by":"crossref","unstructured":"Klaus B (2016) An end to end workflow for differential gene expression using Affymetrix microarrays. F1000Research 5","DOI":"10.12688\/f1000research.8967.1"},{"key":"1032_CR71","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier L, Cope L, Bolstad BM, Irizarry RA (2004) Affy\u2014analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20:307\u2013315. https:\/\/doi.org\/10.1093\/bioinformatics\/btg405","journal-title":"Bioinformatics"},{"key":"1032_CR72","doi-asserted-by":"crossref","unstructured":"Smyth G (2005) limma: linear models for microarray data. Bioinforma Comput Biol Solut Using R Bioconductor:397\u2013420","DOI":"10.1007\/0-387-29362-0_23"},{"key":"1032_CR73","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2008","unstructured":"Huang DW, Sherman BT, Lempicki RA (2008) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44\u201357. https:\/\/doi.org\/10.1038\/nprot.2008.211","journal-title":"Nat Protoc"},{"key":"1032_CR74","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"D Botstein","year":"2000","unstructured":"Botstein D, Cherry JM, Ashburner M et al (2000) Gene ontology: tool for the unification of biology. Nat Genet 25:25\u201329","journal-title":"Nat Genet"},{"key":"1032_CR75","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545\u201315550","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1032_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013984","volume":"5","author":"D Merico","year":"2010","unstructured":"Merico D, Isserlin R, Stueker O, Emili A, Bader GD (2010) Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One 5:e13984. https:\/\/doi.org\/10.1371\/journal.pone.0013984","journal-title":"PLoS One"},{"key":"1032_CR77","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498\u20132504","journal-title":"Genome Res"},{"key":"1032_CR78","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/978-1-61779-276-2_12","volume-title":"Network biology","author":"D Merico","year":"2011","unstructured":"Merico D, Isserlin R, Bader GD (2011) Visualizing gene-set enrichment results using the Cytoscape plug-in enrichment map. In: Cagney G, Emili A (eds) Network biology. Humana Press, Totowa, NJ, pp. 257\u2013277"},{"key":"1032_CR79","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.12688\/f1000research.9090.1","volume":"5","author":"M Kucera","year":"2016","unstructured":"Kucera M, Isserlin R, Arkhangorodsky A, Bader G (2016) AutoAnnotate: a Cytoscape app for summarizing networks with semantic annotations [version 1; referees: 2 approved]. F1000Research 5:1717. https:\/\/doi.org\/10.12688\/f1000research.9090.1","journal-title":"F1000Research"},{"key":"1032_CR80","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1751-0473-6-7","volume":"6","author":"L Oesper","year":"2011","unstructured":"Oesper L, Merico D, Isserlin R, Bader GD (2011) WordCloud: a Cytoscape plugin to create a visual semantic summary of networks. Source Code Biol Med 6:7","journal-title":"Source Code Biol Med"},{"key":"1032_CR81","doi-asserted-by":"publisher","first-page":"M173","DOI":"10.1093\/gerona\/57.3.M173","volume":"57","author":"PM Doraiswamy","year":"2002","unstructured":"Doraiswamy PM, Leon J, Cummings JL, Marin D, Neumann PJ (2002) Prevalence and impact of medical comorbidity in Alzheimer\u2019s disease. J Gerontol A Biol Sci Med Sci 57:M173\u2013M177","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1032_CR82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177044","volume":"12","author":"ML Haaksma","year":"2017","unstructured":"Haaksma ML, Vilela LR, Marengoni A, Calder\u00f3n-Larra\u00f1aga A, Leoutsakos JMS, Olde Rikkert MGM, Melis RJF (2017) Comorbidity and progression of late onset Alzheimer\u2019s disease: a systematic review. PLoS One 12:e0177044. https:\/\/doi.org\/10.1371\/journal.pone.0177044","journal-title":"PLoS One"},{"key":"1032_CR83","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA et al (2008) Amyloid-\u03b2 protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med 14:837\u2013842. https:\/\/doi.org\/10.1038\/nm1782","journal-title":"Nat Med"},{"key":"1032_CR84","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid [beta] protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535\u2013539. https:\/\/doi.org\/10.1038\/416535a","journal-title":"Nature"},{"issue":"7","key":"1032_CR85","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nn.2583","volume":"13","author":"Jorge J Palop","year":"2010","unstructured":"Palop JJ, Mucke L (2010) Amyloid-\u03b2-induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks. Nat Neurosci 13:812\u2013818. https:\/\/doi.org\/10.1038\/nn.2583","journal-title":"Nature Neuroscience"},{"key":"1032_CR86","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1002\/j.1460-2075.1992.tb05272.x","volume":"11","author":"G Drewes","year":"1992","unstructured":"Drewes G, Lichtenberg-Kraag B, D\u00f6ring F et al (1992) Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J 11:2131","journal-title":"EMBO J"},{"key":"1032_CR87","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0169-328X(02)00488-6","volume":"109","author":"J-J Pei","year":"2002","unstructured":"Pei J-J, Braak H, An W-L, Winblad B, Cowburn RF, Iqbal K, Grundke-Iqbal I (2002) Up-regulation of mitogen-activated protein kinases ERK1\/2 and MEK1\/2 is associated with the progression of neurofibrillary degeneration in Alzheimer\u2019s disease. Mol Brain Res 109:45\u201355","journal-title":"Mol Brain Res"},{"key":"1032_CR88","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.neuropharm.2009.11.010","volume":"58","author":"L Munoz","year":"2010","unstructured":"Munoz L, Ammit AJ (2010) Targeting p38 MAPK pathway for the treatment of Alzheimer\u2019s disease. Neuropharmacology 58:561\u2013568. https:\/\/doi.org\/10.1016\/j.neuropharm.2009.11.010","journal-title":"Neuropharmacology"},{"key":"1032_CR89","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/jmcb\/mjt051","volume":"6","author":"NC Inestrosa","year":"2014","unstructured":"Inestrosa NC, Varela-Nallar L (2014) Wnt signaling in the nervous system and in Alzheimer\u2019s disease. J Mol Cell Biol 6:64\u201374. https:\/\/doi.org\/10.1093\/jmcb\/mjt051","journal-title":"J Mol Cell Biol"},{"key":"1032_CR90","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuron.2014.08.048","volume":"84","author":"C-C Liu","year":"2014","unstructured":"Liu C-C, Tsai C-W, Deak F, Rogers J, Penuliar M, Sung YM, Maher JN, Fu Y et al (2014) Deficiency in LRP6-mediated Wnt signaling contributes to synaptic abnormalities and amyloid pathology in Alzheimer\u2019s disease. Neuron 84:63\u201377. https:\/\/doi.org\/10.1016\/j.neuron.2014.08.048","journal-title":"Neuron"},{"key":"1032_CR91","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/j.1471-4159.2004.02766.x","volume":"91","author":"PF Good","year":"2004","unstructured":"Good PF, Alapat D, Hsu A, Chu C, Perl D, Wen X, Burstein DE, Kohtz DS (2004) A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer\u2019s disease. J Neurochem 91:716\u2013736. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02766.x","journal-title":"J Neurochem"},{"key":"1032_CR92","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tins.2008.11.006","volume":"32","author":"L Lin","year":"2009","unstructured":"Lin L, Lesnick TG, Maraganore DM, Isacson O (2009) Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics. Trends Neurosci 32:142\u2013149. https:\/\/doi.org\/10.1016\/j.tins.2008.11.006","journal-title":"Trends Neurosci"},{"key":"1032_CR93","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.nbd.2005.09.004","volume":"21","author":"L Emilsson","year":"2006","unstructured":"Emilsson L, Saetre P, Jazin E (2006) Alzheimer\u2019s disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling. Neurobiol Dis 21:618\u2013625. https:\/\/doi.org\/10.1016\/j.nbd.2005.09.004","journal-title":"Neurobiol Dis"},{"key":"1032_CR94","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nrn960","volume":"3","author":"FM LaFerla","year":"2002","unstructured":"LaFerla FM (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer\u2019s disease. Nat Rev Neurosci 3:862\u2013872. https:\/\/doi.org\/10.1038\/nrn960","journal-title":"Nat Rev Neurosci"},{"key":"1032_CR95","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00401-011-0865-4","volume":"122","author":"D Riascos","year":"2011","unstructured":"Riascos D, de Leon D, Baker-Nigh A, Nicholas A, Yukhananov R, Bu J, Wu CK, Geula C (2011) Age-related loss of calcium buffering and selective neuronal vulnerability in Alzheimer\u2019s disease. Acta Neuropathol (Berl) 122:565\u2013576. https:\/\/doi.org\/10.1007\/s00401-011-0865-4","journal-title":"Acta Neuropathol (Berl)"},{"key":"1032_CR96","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3233\/JAD-2010-100159","volume":"21","author":"O Nelson","year":"2010","unstructured":"Nelson O, Supnet C, Liu H, Bezprozvanny I (2010) Familial Alzheimer\u2019s disease mutations in presenilins: effects on endoplasmic reticulum calcium homeostasis and correlation with clinical phenotypes. J Alzheimers Dis 21:781\u2013793","journal-title":"J Alzheimers Dis"},{"key":"1032_CR97","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4161\/pri.21767","volume":"7","author":"MJ Berridge","year":"2013","unstructured":"Berridge MJ (2013) Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia. Prion 7:2\u201313","journal-title":"Prion"},{"key":"1032_CR98","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1073\/pnas.0308512100","volume":"101","author":"EM Blalock","year":"2004","unstructured":"Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW (2004) Incipient Alzheimer\u2019s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A 101:2173\u20132178","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7539","key":"1032_CR99","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature14252","volume":"518","author":"Elizabeta Gjoneska","year":"2015","unstructured":"Gjoneska E, Pfenning AR, Mathys H, Quon G, Kundaje A, Tsai LH, Kellis M (2015) Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer\u2019s disease. Nature 518:365\u2013369. https:\/\/doi.org\/10.1038\/nature14252","journal-title":"Nature"},{"issue":"5580","key":"1032_CR100","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J. Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297:353\u2013356","journal-title":"Science"},{"key":"1032_CR101","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00702-014-1293-0","volume":"122","author":"PF Durrenberger","year":"2015","unstructured":"Durrenberger PF, Fernando FS, Kashefi SN, Bonnert TP, Seilhean D, Nait-Oumesmar B, Schmitt A, Gebicke-Haerter PJ et al (2015) Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study. J Neural Transm 122:1055\u20131068. https:\/\/doi.org\/10.1007\/s00702-014-1293-0","journal-title":"J Neural Transm"},{"key":"1032_CR102","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/cdd.2014.112","volume":"22","author":"A Wilczynska","year":"2015","unstructured":"Wilczynska A, Bushell M (2015) The complexity of miRNA-mediated repression. Cell Death Differ 22:22\u201333","journal-title":"Cell Death Differ"},{"key":"1032_CR103","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.15252\/embj.201387576","volume":"33","author":"J Banzhaf-Strathmann","year":"2014","unstructured":"Banzhaf-Strathmann J, Benito E, May S, Arzberger T, Tahirovic S, Kretzschmar H, Fischer A, Edbauer D (2014) MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer\u2019s disease. EMBO J 33:1667\u20131680. https:\/\/doi.org\/10.15252\/embj.201387576","journal-title":"EMBO J"},{"key":"1032_CR104","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/WNR.0b013e3280148e8b","volume":"18","author":"WJ Lukiw","year":"2007","unstructured":"Lukiw WJ (2007) Micro-RNA speciation in fetal, adult and Alzheimer\u2019s disease hippocampus. Neuroreport 18:297\u2013300","journal-title":"Neuroreport"},{"key":"1032_CR105","first-page":"105","volume":"3","author":"WJ Lukiw","year":"2012","unstructured":"Lukiw WJ, Surjyadipta B, Dua P, Alexandrov PN (2012) Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer\u2019s disease (AD) and in age-related macular degeneration (AMD). Int J Biochem Mol Biol 3:105","journal-title":"Int J Biochem Mol Biol"},{"key":"1032_CR106","doi-asserted-by":"publisher","first-page":"30105","DOI":"10.3390\/ijms161226223","volume":"16","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Pogue A, Lukiw W (2015) MicroRNA (miRNA) signaling in the human CNS in sporadic Alzheimer\u2019s disease (AD)-novel and unique pathological features. Int J Mol Sci 16:30105\u201330116. https:\/\/doi.org\/10.3390\/ijms161226223","journal-title":"Int J Mol Sci"},{"key":"1032_CR107","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2013.10.002","volume":"336","author":"L Tan","year":"2014","unstructured":"Tan L, Yu J-T, Liu Q-Y, Tan MS, Zhang W, Hu N, Wang YL, Sun L et al (2014) Circulating miR-125b as a biomarker of Alzheimer\u2019s disease. J Neurol Sci 336:52\u201356. https:\/\/doi.org\/10.1016\/j.jns.2013.10.002","journal-title":"J Neurol Sci"},{"key":"1032_CR108","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-160835","volume":"55","author":"TA Lusardi","year":"2016","unstructured":"Lusardi TA, Phillips JI, Wiedrick JT, Harrington CA, Lind B, Lapidus JA, Quinn JF, Saugstad JA (2016) MicroRNAs in human cerebrospinal fluid as biomarkers for Alzheimer\u2019s disease. J Alzheimers Dis 55:1223\u20131233. https:\/\/doi.org\/10.3233\/JAD-160835","journal-title":"J Alzheimers Dis"},{"key":"1032_CR109","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nn.3599","volume":"17","author":"O Butovsky","year":"2013","unstructured":"Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B et al (2013) Identification of a unique TGF-\u03b2-dependent molecular and functional signature in microglia. Nat Neurosci 17:131\u2013143. https:\/\/doi.org\/10.1038\/nn.3599","journal-title":"Nat Neurosci"},{"key":"1032_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/2584940","volume":"2016","author":"D Villela","year":"2016","unstructured":"Villela D, Ramalho RF, Silva ART, Brentani H, Suemoto CK, Pasqualucci CA, Grinberg LT, Krepischi ACV et al (2016) Differential DNA methylation of microRNA genes in temporal cortex from Alzheimer\u2019s disease individuals. Neural Plast 2016:1\u201310. https:\/\/doi.org\/10.1155\/2016\/2584940","journal-title":"Neural Plast"},{"key":"1032_CR111","doi-asserted-by":"publisher","first-page":"13748","DOI":"10.1074\/jbc.M112.381392","volume":"288","author":"C Cheng","year":"2013","unstructured":"Cheng C, Li W, Zhang Z, Yoshimura S, Hao Q, Zhang C, Wang Z (2013) MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10). J Biol Chem 288:13748\u201313761. https:\/\/doi.org\/10.1074\/jbc.M112.381392","journal-title":"J Biol Chem"},{"key":"1032_CR112","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/mp.2014.127","volume":"20","author":"L Cheng","year":"2015","unstructured":"Cheng L, Doecke JD, Sharples RA et al (2015) Prognostic serum miRNA biomarkers associated with Alzheimer\u2019s disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry 20:1188\u20131196","journal-title":"Mol Psychiatry"},{"key":"1032_CR113","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1523\/JNEUROSCI.0600-12.2013","volume":"33","author":"A Jovicic","year":"2013","unstructured":"Jovicic A, Roshan R, Moisoi N, Pradervand S, Moser R, Pillai B, Luthi-Carter R (2013) Comprehensive expression analyses of neural cell-type-specific miRNAs identify new determinants of the specification and maintenance of neuronal phenotypes. J Neurosci 33:5127\u20135137. https:\/\/doi.org\/10.1523\/JNEUROSCI.0600-12.2013","journal-title":"J Neurosci"},{"key":"1032_CR114","doi-asserted-by":"publisher","unstructured":"Maciotta S, Meregalli M, Torrente Y (2013) The involvement of microRNAs in neurodegenerative diseases. Front Cell Neurosci 7. https:\/\/doi.org\/10.3389\/fncel.2013.00265","DOI":"10.3389\/fncel.2013.00265"},{"key":"1032_CR115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121975","volume":"10","author":"Y Wan","year":"2015","unstructured":"Wan Y, Liu Y, Wang X, Wu J, Liu K, Zhou J, Liu L, Zhang C (2015) Identification of differential microRNAs in cerebrospinal fluid and serum of patients with major depressive disorder. PLoS One 10:e0121975. https:\/\/doi.org\/10.1371\/journal.pone.0121975","journal-title":"PLoS One"},{"key":"1032_CR116","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1158\/1078-0432.CCR-08-1818","volume":"15","author":"E Bandres","year":"2009","unstructured":"Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA et al (2009) microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 15:2281\u20132290. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-1818","journal-title":"Clin Cancer Res"},{"key":"1032_CR117","first-page":"263","volume":"1","author":"HM Schipper","year":"2007","unstructured":"Schipper HM, Maes OC, Chertkow HM, Wang E (2007) MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul Syst Biol 1:263","journal-title":"Gene Regul Syst Biol"},{"key":"1032_CR118","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/emboj.2010.347","volume":"30","author":"J Xiao","year":"2011","unstructured":"Xiao J, Lin H, Luo X, Luo X, Wang Z (2011) miR-605 joins p53 network to form a p53: miR-605: Mdm2 positive feedback loop in response to stress. EMBO J 30:524\u2013532","journal-title":"EMBO J"},{"key":"1032_CR119","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.3892\/or.2017.5740","volume":"38","author":"L Chen","year":"2017","unstructured":"Chen L, Cao Y, Rong D, Wang Y, Cao Y (2017) MicroRNA-605 functions as a tumor suppressor by targeting INPP4B in melanoma. Oncol Rep 38:1276\u20131286. https:\/\/doi.org\/10.3892\/or.2017.5740","journal-title":"Oncol Rep"},{"key":"1032_CR120","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1038\/s41598-017-02969-6","volume":"7","author":"R Raoof","year":"2017","unstructured":"Raoof R, Jimenez-Mateos EM, Bauer S, Tackenberg B, Rosenow F, Lang J, Onugoren MD, Hamer H et al (2017) Cerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticus. Sci Rep 7:3328. https:\/\/doi.org\/10.1038\/s41598-017-02969-6","journal-title":"Sci Rep"},{"key":"1032_CR121","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170628","volume":"12","author":"I Helwa","year":"2017","unstructured":"Helwa I, Cai J, Drewry MD, Zimmerman A, Dinkins MB, Khaled ML, Seremwe M, Dismuke WM et al (2017) A comparative study of serum exosome isolation using differential ultracentrifugation and three commercial reagents. PLoS One 12:e0170628. https:\/\/doi.org\/10.1371\/journal.pone.0170628","journal-title":"PLoS One"},{"key":"1032_CR122","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1172\/JCI81129","volume":"126","author":"R Xu","year":"2016","unstructured":"Xu R, Greening DW, Zhu H-J, Takahashi N, Simpson RJ (2016) Extracellular vesicle isolation and characterization: toward clinical application. J Clin Invest 126:1152\u20131162. https:\/\/doi.org\/10.1172\/JCI81129","journal-title":"J Clin Invest"},{"key":"1032_CR123","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v3.24858","volume":"3","author":"J Deun Van","year":"2014","unstructured":"Van Deun J, Mestdagh P, Sormunen R et al (2014) The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J Extracell Vesicles 3:24858. https:\/\/doi.org\/10.3402\/jev.v3.24858","journal-title":"J Extracell Vesicles"},{"key":"1032_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.33","volume":"4","author":"S Parsi","year":"2015","unstructured":"Parsi S, Smith PY, Goupil C, Dorval V, H\u00e9bert SS (2015) Preclinical evaluation of miR-15\/107 family members as multifactorial drug targets for Alzheimer\u2019s disease. Mol Ther - Nucleic Acids 4:e256. https:\/\/doi.org\/10.1038\/mtna.2015.33","journal-title":"Mol Ther - Nucleic Acids"},{"key":"1032_CR125","first-page":"4020","volume":"19","author":"B Zhang","year":"2015","unstructured":"Zhang B, Chen CF, Wang AH, Lin QF (2015) MiR-16 regulates cell death in Alzheimer\u2019s disease by targeting amyloid precursor protein. Eur Rev Med Pharmacol Sci 19:4020\u20134027","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-1032-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1032-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1032-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T15:04:44Z","timestamp":1570979084000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-1032-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,30]]},"references-count":125,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1032"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-1032-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,30]]},"assertion":[{"value":"11 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}